AMB-CHMINACA
AMB-CHMINACA is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the cannabinoid receptors and has been associated with numerous adverse effects and fatalities.
Chemical Structure and Properties[edit | edit source]
AMB-CHMINACA, also known as MMB-CHMINACA, is chemically classified as an indazole-based synthetic cannabinoid. Its full chemical name is (S)-methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate. The compound is structurally related to other synthetic cannabinoids such as AB-FUBINACA and ADB-CHMINACA.
Pharmacology[edit | edit source]
AMB-CHMINACA acts as a potent agonist of the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain sensation, mood, and appetite. The high potency of AMB-CHMINACA at these receptors is responsible for its strong psychoactive effects.
Adverse Effects[edit | edit source]
The use of AMB-CHMINACA has been linked to a range of adverse effects, including tachycardia, hypertension, nausea, vomiting, agitation, hallucinations, and seizures. In severe cases, it can lead to acute kidney injury, myocardial infarction, and death. The variability in the potency and purity of synthetic cannabinoid products increases the risk of overdose and severe adverse effects.
Legal Status[edit | edit source]
The legal status of AMB-CHMINACA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and harmful effects. For example, in the United States, it is listed as a Schedule I controlled substance under the Controlled Substances Act.
Detection in Biological Samples[edit | edit source]
AMB-CHMINACA and its metabolites can be detected in biological samples such as urine and blood using techniques like liquid chromatography-mass spectrometry (LC-MS). These tests are often used in forensic and clinical settings to confirm exposure to the substance.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
